Commonwealth Equity Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $203K | Sell |
|
|||||
|
2024
Q3 | $330K | Buy |
|
|||||
|
2024
Q2 | $293K | Buy |
|
|||||
|
2024
Q1 | $292K | Buy |
|
|||||
|
2023
Q4 | $254K | Buy |
|
|||||
|
2023
Q3 | $235K | Sell |
|
|||||
|
2023
Q2 | $270K | Buy |
|
|||||
|
2023
Q1 | $258 | Buy |
|
|||||
|
2022
Q4 | $217K | Sell |
|
|||||
|
2022
Q3 | $227K | Buy |
|
|||||
|
2022
Q2 | $199K | Buy |
|
|||||
|
2022
Q1 | $210K | Sell |
|
|||||
|
2021
Q4 | $654K | Sell |
|
|||||
|
2021
Q3 | $685K | Buy |
|
|||||
|
2021
Q2 | $747K | Sell |
|
|||||
|
2021
Q1 | $729K | Sell |
|
|||||
|
2020
Q4 | $772K | Sell |
|
|||||
|
2020
Q3 | $812K | Sell |
|
|||||
|
2020
Q2 | $3.74M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $234K | Sell |
|
|||||
|
2019
Q3 | $1.01M | Sell |
|
|||||
|
2019
Q2 | $1.18M | Sell |
|
|||||
|
2019
Q1 | $1.29M | Sell |
|
|||||
|
2018
Q4 | $1.15M | Sell |
|
|||||
|
2018
Q3 | $1.52M | Buy |
|
|||||
|
2018
Q2 | $356K | Sell |
|
|||||
|
2018
Q1 | $426K | Sell |
|
|||||
|
2017
Q4 | $528K | Sell |
|
|||||
|
2017
Q3 | $580K | Buy |
|
|||||
|
2017
Q2 | $578K | Sell |
|
|||||
|
2017
Q1 | $1.69M | Buy |
|
|||||
|
2016
Q4 | $500K | Sell |
|
|||||
|
2016
Q3 | $603K | Buy |
|
|||||
|
2016
Q2 | $570K | Sell |
|
|||||
|
2016
Q1 | $552K | Sell |
|
|||||
|
2015
Q4 | $723K | Sell |
|
|||||
|
2015
Q3 | $717K | Sell |
|
|||||
|
2015
Q2 | $1.54M | Buy |
|
|||||
|
2015
Q1 | $1.51M | Buy |
|
|||||
|
2014
Q4 | $806K | Sell |
|
|||||
|
2014
Q3 | $1.1M | Sell |
|
|||||
|
2014
Q2 | $1.09M | Buy |
|
|||||
|
2014
Q1 | $861K | Buy |
|
|||||
|
2013
Q4 | $594K | Buy |
|
|||||
|
2013
Q3 | $466K | Buy |
|
|||||
|
2013
Q2 | $285K | Buy |
|